Tandem Diabetes Care, Inc.
https://www.tandemdiabetes.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Tandem Diabetes Care, Inc.
Dexcom CEO Talks Stelo Launch, Broader Plans, And GLP1 Misconceptions
Medtech Insight spoke to Dexcom CEO Kevin Sayer, ahead of this year’s Advanced Technologies & Treatments for Diabetes conference, to get an update on the company’s recent news, future strategy and where he feels his company’s market is headed.
JPM Day 1: Abbott Riding In Tandem With Libre 2 Plus & t:slim X2 News
The two diabetes players announced a new integration between their products.
Medtronic Is Not Going With The EOFlow – Deal Cancelled
Medtronic is dropping plans to acquire EOFlow, which has faced numerous patent lawsuits from Insulet.
No, I Am Spartacus – Embecta Joins The Quell Against GLP-1 Hype
Embecta, which recently completed its spin-off from Becton Dickinson, is forging ahead with its insulin injector-based business strategy, GLP-1s be damned.
Company Information
- Industry
-
Pharmaceuticals
- Drug Delivery
-
Medical Devices
- Monitoring Equipment & Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
In Vitro Diagnostics
- Glucose Testing
- Other Names / Subsidiaries
-
- AMF Medical
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice